Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Atlantic American Corporation is an insurance-life business based in the US. Atlantic American Corporation shares (AAME) are listed on the NASDAQ and all prices are listed in US Dollars. Atlantic American Corporation employs 152 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$4.33|
|52-week range||$1.99 - $7.46|
|50-day moving average||$4.08|
|200-day moving average||$4.09|
|Wall St. target price||N/A|
|Dividend yield||$0.02 (0.45%)|
|Earnings per share (TTM)||$0.75|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||-3.56%|
|1 month (2021-09-17)||8.25%|
|3 months (2021-07-16)||5.87%|
|6 months (2021-04-16)||17.03%|
|1 year (2020-10-16)||96.82%|
|2 years (2019-10-17)||76.02%|
|3 years (2018-10-17)||46.78%|
|5 years (2016-10-17)||15.47%|
Valuing Atlantic American Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Atlantic American Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Atlantic American Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 6x. In other words, Atlantic American Corporation shares trade at around 6x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Atlantic American Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $23.1 million.
The EBITDA is a measure of a Atlantic American Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$206.7 million|
|Operating margin TTM||10.68%|
|Gross profit TTM||$28.7 million|
|Return on assets TTM||3.49%|
|Return on equity TTM||12.21%|
|Market capitalisation||$88.4 million|
TTM: trailing 12 months
There are currently 153,027 Atlantic American Corporation shares held short by investors – that's known as Atlantic American Corporation's "short interest". This figure is 45.5% down from 280,835 last month.
There are a few different ways that this level of interest in shorting Atlantic American Corporation shares can be evaluated.
Atlantic American Corporation's "short interest ratio" (SIR) is the quantity of Atlantic American Corporation shares currently shorted divided by the average quantity of Atlantic American Corporation shares traded daily (recently around 51179.598662207). Atlantic American Corporation's SIR currently stands at 2.99. In other words for every 100,000 Atlantic American Corporation shares traded daily on the market, roughly 2990 shares are currently held short.
However Atlantic American Corporation's short interest can also be evaluated against the total number of Atlantic American Corporation shares, or, against the total number of tradable Atlantic American Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Atlantic American Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Atlantic American Corporation shares in existence, roughly 10 shares are currently held short) or 0.035% of the tradable shares (for every 100,000 tradable Atlantic American Corporation shares, roughly 35 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Atlantic American Corporation.
Find out more about how you can short Atlantic American Corporation stock.
Dividend payout ratio: 2.49% of net profits
Recently Atlantic American Corporation has paid out, on average, around 2.49% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.46% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Atlantic American Corporation shareholders could enjoy a 0.46% return on their shares, in the form of dividend payments. In Atlantic American Corporation's case, that would currently equate to about $0.02 per share.
While Atlantic American Corporation's payout ratio might seem low, this can signify that Atlantic American Corporation is investing more in its future growth.
Atlantic American Corporation's most recent dividend payout was on 26 April 2021. The latest dividend was paid out to all shareholders who bought their shares by 11 April 2021 (the "ex-dividend date").
Atlantic American Corporation's shares were split on a 5:4 basis on 3 November 1986. So if you had owned 4 shares the day before before the split, the next day you'd have owned 5 shares. This wouldn't directly have changed the overall worth of your Atlantic American Corporation shares – just the quantity. However, indirectly, the new 20% lower share price could have impacted the market appetite for Atlantic American Corporation shares which in turn could have impacted Atlantic American Corporation's share price.
Over the last 12 months, Atlantic American Corporation's shares have ranged in value from as little as $1.9896 up to $7.4611. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Atlantic American Corporation's is 0.1582. This would suggest that Atlantic American Corporation's shares are less volatile than average (for this exchange).
Atlantic American Corporation, through its subsidiaries, provides life and health, and property and casualty insurance products in the United States. It operates through American Southern and Bankers Fidelity segments. The company offers property and casualty insurance products, including business automobile insurance coverage for state governments, local municipalities, and other motor pools and fleets; and inland marine and general liability insurance products. It also provides surety bond coverage for subdivision construction, as well as performance and payment bonds. In addition, it provides term, individual and group whole life insurance, as well as medicare supplement and other accident and health insurance products. The company markets its products through independent agents and brokers. Atlantic American Corporation was founded in 1937 and is headquartered in Atlanta, Georgia.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.